Isto Technologies

Isto Technologies is owned by Thompson Street Capital Partners.

They are in:

• Biotechnology67%
• Financial Services33%

View the org chart displaying its 10 main executives

Most searched biographies at Isto Technologies

• Don Brown, Chief Executive Officer
• Kenneth Galbraith, General Counsel
• Neil Kizer, Vice President, Regulatory and Quality Assurance

Create your alert
to follow the executive moves at Isto Technologies.

Thompson Street Capital Partners has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Isto Technologies

• Isto Biologics
• Isto Biologics
• Isto Biologics

Social media about Isto Technologies

• Isto Technologies on Wikipedia, Google News & Yahoo Finance
• Isto Technologies on LinkedIn, Twitter & YouTube

Contact by email its executives including Don Brown

Call Isto Technologies at +1 314...

View the org chart

Register to receive your alert

Report an error